Assessing the biocompatibility and stability of CeO<sub>2</sub> nanoparticle conjugates with azacrowns for use as radiopharmaceuticals
Sofia Khabirova, Mikhail Menshikov-Tonyan, Gleb Yu. Aleshin, Anastasia S. Prikhodko, D. A. Kozlov, Evgeny O. Anokhin, Konstantin A. Babeshkin, Nikolay Titchenko, Anastasia D. Zubenko, Anna A. Shchukina, Yu. V. Fedorov, Stepan N. Kalmykov
Abstract
stability of the studied scandium complex was demonstrated. Taken together, our studies show that functionalised cerium oxide nanoparticles lead to stable radiolabelled nanosystems that may be used for targeted drug delivery, diagnosis and treatment of oncological diseases.
Topics & Concepts
BiocompatibilityNanoparticleConjugateNanotechnologyChemistryMaterials scienceMathematicsOrganic chemistryMathematical analysisRadiopharmaceutical Chemistry and ApplicationsNanoparticle-Based Drug DeliveryRadioactive element chemistry and processing